GROWTH OF A LOCAL TUMOR EXERTS A SPECIFIC INHIBITORY EFFECT ON PROGRESSION OF LUNG METASTASES

The effects of local tumor growth on the progression of lung metastasis of two mouse tumors of C57BL origin—the 3LL Lewis lung carcinoma and the B‐16 melanoma—were studied. Excision of primary footpad grafts of 3LL or B‐16 resulted in a significant increase in incidence and size of lung metastases. The incidence, but not the size, of lung metastases was found to be a function of size of the local tumor at time of excision. Reinoculation of tumor cells in the left footpad following excision of tumor from the right footpad suppressed the acceleration of growth of lung metastases and their increased incidence. Thus, the progression of the local tumor exerts an inhibitory effect on lung metastasis. The extent of inhibition of accelerated metastatic development by reinoculated tumor cells is a function of size of the cell inoculum or, in fact, of mass of the local tumor. The inhibitory effect of the local tumor on lung metastasis seems to be tumor‐specific. 3LL metastases were not inhibited by local B‐16 or EL4, neither was B‐16 metastasis inhibited by 3LL. The specificity of interactions between the local tumor growth and its metastases may suggest the participation of immunological mechanisms in the control of lung metastasis. The involvement of the lymphoid system in the control of metastatic progression is also supported by the observation that total‐body X‐irradiation was associated with an increase in lung metastasis and that splenomegaly was observed in mice bearing the footpad tumor. Its excision resulted in the prevention of splenomegaly but reinoculation of the tumor, leading to metastatic suppression, was again associated with splenomegaly.

[1]  J. Castro,et al.  Immunological mechanisms in metastatic spread and the antimetastatic effects of C. parvum. , 1977, British Journal of Cancer.

[2]  I. Fidler,et al.  Enhancement of experimental metastasis by x-ray: a possible mechanism. , 1972, Journal of medicine.

[3]  I. Fidler,et al.  Metastasis results from preexisting variant cells within a malignant tumor. , 1977, Science.

[4]  R. Prehn,et al.  Immunity to methylcholanthrene-induced sarcomas. , 1957, Journal of the National Cancer Institute.

[5]  N. Mantel,et al.  The development of spontaneous metastases after the removal of a “primary” tumor II. Standardization protocol of 5 animal tumors , 1961, Cancer.

[6]  R. Gershon,et al.  Facilitation of Metastatic Growth by Antilymphocyte Serum , 1970, Nature.

[7]  R. Gershon,et al.  Immunologic Defenses against Metastases: Impairment by Excision of an Allotransplanted Lymphoma , 1968, Science.

[8]  W. Schatten,et al.  An experimental study of postoperative tumor metastases. II. Effects of anesthesia, operation, and cortisone administration on growth of pulmonary metastases , 1958, Cancer.

[9]  W. Schatten An experimental study of postoperative tumor metastases. I. Growth of pulmonary metastases following total removal of primary leg tumor , 1958, Cancer.

[10]  S. Segal,et al.  Specific cytotoxic lymphocytes against syngeneic tumors are generated in culture in the presence of syngeneic, but not xenogeneic, serum , 1978, International journal of cancer.

[11]  D. W. Weiss,et al.  ACQUISITION OF HEIGHTENED RESISTANCE AND SUSCEPTIBILITY TO SPONTANEOUS MOUSE MAMMARY CARCINOMAS IN THE ORIGINAL HOST. , 1964, Cancer research.

[12]  H. Greene,et al.  The inhibitory influence of a transplanted hamster lymphoma on metastasis. , 1960, Cancer research.

[13]  Tyzzer Ee,et al.  Factors in the Production and Growth of tumor Metastases. , 1913 .

[14]  I. Cohen,et al.  Enhancing T lymphocytes from tumor‐bearing mice suppress host resistance to a syngeneic tumor , 1974, European journal of immunology.

[15]  G. Klein,et al.  Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. , 1960, Cancer research.